<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>米内网 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-09T16:23:03+08:00</updated>
  <subtitle>米内网是中国领先的集医药健康产业研究、医院市场研究、零售市场研究、商业渠道研究、互联网在线医药健康信息服务于一体的综合性专业信息服务平台。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>东阳光药、恒瑞独家产品首破10亿，双鲸拿下20亿品牌，零售千亿市场超“燃”</title>
    <updated>2020-11-09T16:03:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/AbYd4dOut-SuoPCpM1D5GQ</id>
    <link href="https://mp.weixin.qq.com/s/AbYd4dOut-SuoPCpM1D5GQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【10周年献礼】上海医药：米内网的产品战略方法论我们一直在延用和更新</title>
    <updated>2020-11-09T16:03:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/olG0M7fr9J6jfB5l5z-Xxw</id>
    <link href="https://mp.weixin.qq.com/s/olG0M7fr9J6jfB5l5z-Xxw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【重磅】齐鲁将拿下“乙肝神药”！原研药上半年卖出超1亿</title>
    <updated>2020-11-09T16:03:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/RhuZFI9rsrqzEgpy-2wXkQ</id>
    <link href="https://mp.weixin.qq.com/s/RhuZFI9rsrqzEgpy-2wXkQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【瞩目】豪森又有新药来了！加码40亿神经系统大品种</title>
    <updated>2020-11-09T16:03:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/PTxXF2GQ3sAaINoJAwycRA</id>
    <link href="https://mp.weixin.qq.com/s/PTxXF2GQ3sAaINoJAwycRA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>4322亿！2020年零售终端药品销售增速下滑显著，处方药及非处方药TOP10出炉</title>
    <updated>2020-11-08T08:12:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-08:/s/65u-TaL0JGG9mv7n8Q35fg</id>
    <link href="https://mp.weixin.qq.com/s/65u-TaL0JGG9mv7n8Q35fg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>正大天晴、泰德......42个新药获批临床！“医药股一哥”大爆发，齐鲁进攻高端制剂</title>
    <updated>2020-11-08T08:12:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-08:/s/JtUN_wl73eFdaHuMjqRQgQ</id>
    <link href="https://mp.weixin.qq.com/s/JtUN_wl73eFdaHuMjqRQgQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>原料药3亿罚单后，17家药企被点名降价！111个药调出医保，超70位医药人入围中国富豪榜</title>
    <updated>2020-11-07T07:58:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-07:/s/RUI6UAVmdltQT5iuvHGhMg</id>
    <link href="https://mp.weixin.qq.com/s/RUI6UAVmdltQT5iuvHGhMg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>51款注射剂厉害！正大天晴、恒瑞、齐鲁领跑过评榜，一致性评价、集采冲击6000亿市场</title>
    <updated>2020-11-06T16:08:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/5xFL4hno-LhpExA6ztS-sQ</id>
    <link href="https://mp.weixin.qq.com/s/5xFL4hno-LhpExA6ztS-sQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【市场】100亿级重磅品种，这家江苏药企拿下</title>
    <updated>2020-11-06T16:08:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/A6RYdiuNUI3n8SWbm6esgw</id>
    <link href="https://mp.weixin.qq.com/s/A6RYdiuNUI3n8SWbm6esgw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【瞩目】4亿抗生素大品种，国产第3家将诞生</title>
    <updated>2020-11-06T16:08:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/cvnngZO9g6oEnYVThISPNA</id>
    <link href="https://mp.weixin.qq.com/s/cvnngZO9g6oEnYVThISPNA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【重磅】这家眼科用药龙头，滴眼剂新品来袭</title>
    <updated>2020-11-06T16:08:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/il-4K0KENMJChWant4hjkQ</id>
    <link href="https://mp.weixin.qq.com/s/il-4K0KENMJChWant4hjkQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>奥赛康首个PPI注射剂过评！挑战“万能靶向药”，1类新药、首仿……迎爆发期</title>
    <updated>2020-11-05T15:54:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/XpNe-O-MoAT4yF_k98lUFA</id>
    <link href="https://mp.weixin.qq.com/s/XpNe-O-MoAT4yF_k98lUFA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【瞩目】四川药企猛攻吸入剂！入局10亿品种，3大吸入剂抢首仿</title>
    <updated>2020-11-05T15:54:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/mgQh3xuwiLFZDvfoaRu47g</id>
    <link href="https://mp.weixin.qq.com/s/mgQh3xuwiLFZDvfoaRu47g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【关注】成都药企爆发了！拿下重磅注射剂，2大新品将获批</title>
    <updated>2020-11-05T15:54:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/6e_CzwoX3WfScvV-DeHayg</id>
    <link href="https://mp.weixin.qq.com/s/6e_CzwoX3WfScvV-DeHayg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【聚焦】汇宇制药又有新品来袭，今年第5个注射剂报产</title>
    <updated>2020-11-05T15:54:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/S9RfUC-vAwC4ESJajgtW9g</id>
    <link href="https://mp.weixin.qq.com/s/S9RfUC-vAwC4ESJajgtW9g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>344家药企三季报出炉！40家亏损，迈瑞、恒瑞……净利润超40亿，16家毛利率超90%</title>
    <updated>2020-11-04T16:27:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/SnRqlJ3sBYSjvf5RxPGrvw</id>
    <link href="https://mp.weixin.qq.com/s/SnRqlJ3sBYSjvf5RxPGrvw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【热点】NEXT主旨演讲人和直播抽奖揭晓！立即注册NEXT CHINA 2020</title>
    <updated>2020-11-04T16:27:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/FqUUvIfINs7yr03pGyWrGA</id>
    <link href="https://mp.weixin.qq.com/s/FqUUvIfINs7yr03pGyWrGA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【瞩目】2亿抗肿瘤药“激战”！正大天晴、齐鲁、石药8家药企抢首仿</title>
    <updated>2020-11-04T16:27:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/GHHCEPM0h4G6XEAuPGO8Ww</id>
    <link href="https://mp.weixin.qq.com/s/GHHCEPM0h4G6XEAuPGO8Ww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【审评】阿斯利康超10亿吸入剂告急？石四药、健康元等蜂拥而至</title>
    <updated>2020-11-04T16:27:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/aptm5_w7lfXfJJxvCO5F-A</id>
    <link href="https://mp.weixin.qq.com/s/aptm5_w7lfXfJJxvCO5F-A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>3000亿市场增速持续下滑，专业化落地成连锁药店进阶重点</title>
    <updated>2020-11-03T15:13:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/WeAwBUOrzAsp8cThHmhntg</id>
    <link href="https://mp.weixin.qq.com/s/WeAwBUOrzAsp8cThHmhntg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>